Company / FCF Margin
AMICUS THERAPEUTICS, INC. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
4.7%
FY2025
5-year range
-67.5% / 4.7%
FY2021-FY2025
Trend
+166.4%
vs FY2024
Sector context
#54 of 134
Health Care
What the data says
At 4.7%, AMICUS THERAPEUTICS, INC.'s fcf margin ranks #54 of 134 in the Health Care sector. FCF Margin has increased for 6 consecutive years, from -3148.4% in FY2016 to 4.7% in FY2025.
Based on SEC 10-K filings.
4.7% in FY2025 with a 3-year CAGR of +56.5%.
Improved from -19.2% to 4.7% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +56.5pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#54 of 134 in Health CareTop 40% of 134This company 4.7% Sector average -637.8%
▼
+100.7% above sector average
Key checks
Key Insights
- AMICUS THERAPEUTICS, INC.'s fcf margin has grown for 4 consecutive years.
- In FY2025, fcf margin increased 166.4% year-over-year.
- Currently 642.5pp above the Health Care sector average.
- Lowest fcf margin in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 4.7% | +166.4% |
| FY2024 | -7.1% | +63.0% |
| FY2023 | -19.2% | +63.0% |
| FY2022 | -51.7% | +23.4% |
| FY2021 | -67.5% | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | -590.9% | +81.2% |
| FY2016 | -3148.4% | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026